The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities
- PMID: 37649296
- DOI: 10.2174/1389201025666230830125147
The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities
Abstract
The expression of aldose reductase leads to a variety of biological and pathological effects. It is a multifunctional enzyme which has a tendency to reduce aldehydes to the corresponding sugar.alcohol. In diabetic conditions, the aldose reductase enzyme converts glucose into sorbitol using nicotinamide adenine dinucleotide phosphate as a cofactor. It is a key enzyme in polyol pathway which is a surrogate course of glucose metabolism. The polyol pathway has a significant impact on the aetiology of complications in individuals with end-stage diabetes. The exorbitant level of sorbitol leads to the accumulation of intracellular reactive oxygen species in diabetic heart, neurons, kidneys, eyes and other vasculatures, leading to many complications and pathogenesis. Recently, the pathophysiological role of aldose reductase has been explored with multifarious perspectives. Research on aldose reductase suggest that besides implying in diabetic complications, the enzyme also turns down the lipid-derived aldehydes as well as their glutathione conjugates. Although aldose reductase has certain lucrative role in detoxification of toxic lipid aldehydes, its overexpression leads to intracellular accumulation of sorbitol which is involved in secondary diabetic complications, such as neuropathy, cataractogenesis, nephropathy, retinopathy and cardiovascular pathogenesis. Osmotic upset and oxidative stress are produced by aldose reductase via the polyol pathway. The inhibition of aldose reductase alters the activation of transcription factors like NF-ƙB. Moreover, in many preclinical studies, aldose reductase inhibitors have been observed to reduce inflammation-related impediments, such as asthma, sepsis and colon cancer, in diabetic subjects. Targeting aldose reductase can bestow a novel cognizance for this primordial enzyme as an ingenious strategy to prevent diabetic complications and associated morbidities. In this review article, the significance of aldose reductase is briefly discussed along with their prospective applications in other afflictions.
Keywords: Diabetes; aldose reductase; nephropathy; neuropathy; polyol pathway.; retinopathy; sorbitol.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.Arch Pharm Res. 2021 Jul;44(7):655-667. doi: 10.1007/s12272-021-01343-5. Epub 2021 Jul 19. Arch Pharm Res. 2021. PMID: 34279787 Review.
-
Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.Mini Rev Med Chem. 2016;16(2):120-62. doi: 10.2174/1389557515666150909143737. Mini Rev Med Chem. 2016. PMID: 26349493 Review.
-
Aldose reductase and its inhibition in the control of diabetic complications.Ann Clin Lab Sci. 1993 Mar-Apr;23(2):148-58. Ann Clin Lab Sci. 1993. PMID: 8457142 Review.
-
Aldose reductase / polyol inhibitors for diabetic retinopathy.Curr Pharm Biotechnol. 2011 Mar 1;12(3):373-85. doi: 10.2174/138920111794480642. Curr Pharm Biotechnol. 2011. PMID: 20939801 Review.
-
A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats.Physiol Res. 2015;64(4):587-91. doi: 10.33549/physiolres.933034. Physiol Res. 2015. PMID: 26291727
Cited by
-
Linking oxidative stress biomarkers to disease progression and antioxidant therapy in hypertension and diabetes mellitus.Front Mol Biosci. 2025 May 26;12:1611842. doi: 10.3389/fmolb.2025.1611842. eCollection 2025. Front Mol Biosci. 2025. PMID: 40492113 Free PMC article. Review.
-
Correlates of retinopathy in persons living with type 2 diabetes at a clinic in Zambia.Pan Afr Med J. 2024 Nov 21;49:83. doi: 10.11604/pamj.2024.49.83.43657. eCollection 2024. Pan Afr Med J. 2024. PMID: 40027085 Free PMC article.
-
Potential Application of Bendazac L-Lysine for Controlling Myopia Progression, as Demonstrated in Two Experimental Guinea Pig Myopia Models.Invest Ophthalmol Vis Sci. 2025 May 1;66(5):46. doi: 10.1167/iovs.66.5.46. Invest Ophthalmol Vis Sci. 2025. PMID: 40440163 Free PMC article.
-
The effects of cynaroside on lipid metabolism and lipid-related diseases: a mechanistic overview.Front Pharmacol. 2025 Jul 31;16:1648614. doi: 10.3389/fphar.2025.1648614. eCollection 2025. Front Pharmacol. 2025. PMID: 40822468 Free PMC article. Review.
-
The Role of Advanced Glycation End-Products in the Pathophysiology and Pharmacotherapy of Cardiovascular Disease.Int J Mol Sci. 2025 Jul 29;26(15):7311. doi: 10.3390/ijms26157311. Int J Mol Sci. 2025. PMID: 40806443 Free PMC article. Review.
References
-
- Van Heyningen R.; Formation of polyols by the lens of the rat with `Sugar' cataract. Nature 1956,184(4681),194-195
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical